Peptidase inhibitor-induced antidiuresis mediated through angiotensin and opioid receptors in the rat hypothalamus

Japanese Journal of Pharmacology

Volumn 71, Issue 1, 1996, Pages 61-71

  Tsushima, Hiromi ^a   Mori, Mayumi ^a   Matsuda, Tomohiro ^a  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

Author keywords

Antidiuresis; Paraventricular nucleus; Peptidase inhibitor; Supraoptic nucleus; Vasopressin

Indexed keywords

ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN RECEPTOR; BESTATIN; ENZYME INHIBITOR; OPIATE RECEPTOR; PEPTIDASE; THIORPHAN; VASOPRESSIN; VASOPRESSIN RECEPTOR;

ANIMAL EXPERIMENT; ANTIDIURESIS; ARTICLE; BREATHING RATE; CONTROLLED STUDY; HEART RATE; HYPOTHALAMUS; MALE; MEAN ARTERIAL PRESSURE; MICROINJECTION; MICTURITION; NONHUMAN; OSMOTIC PRESSURE; RAT; RECTUM TEMPERATURE; SUPRAOPTIC NUCLEUS; THALAMUS MIDLINE NUCLEUS; VASOPRESSIN RELEASE;

EID: 0029952744     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.71.61     Document Type: Article

References (46)

1. Gardiner SM and Bennett T: Brain neuropeptides: actions on central cardiovascular control mechanisms. Brain Res Rev 14, 79-116 (1989)
2. Krieger DT, Brownstein MJ and Martin JB: Brain Peptides, John Wiley & Sons, New York (1983)
3. Heike Y, Hisano S, Tsuruo Y, Katoh S and Daikoku S: Immunocytochemical evidence for synaptic regulation of paraventricular vasopressin-containing neurons by substance P. Brain Res 369, 341-346 (1986)
4. Swanson LW and Sawchenko PE: Hypothalamic integration: organization of the paraventricular and supraoptic nuclei. Annu Rev Neurosci 6, 269-324 (1983)
5. Milton AS and Patterson AT: A microinjection study of the control of antidiuretic hormone release by the supraoptic nucleus of the hypothalamus in the cat. J Physiol (Lond) 241, 607-628 (1974)
6. Tsushima H, Mori M and Matsuda T: Antidiuretic effects of alpha- and beta-adrenoceptor agonists microinjected into the hypothalamic supraoptic nucleus in a water-loaded and ethanol-anesthetized rat. Jpn J Pharmacol 39, 365-374 (1985)
7. Tsushima H, Mori M and Matsuda T: Antidiuretic effects of alpha- and beta-adrenoceptor agonists microinjected into the hypothalamic paraventricular nucleus in a water-loaded and ethanol-anesthetized rat. Jpn J Pharmacol 40, 319-328 (1986)
8. Armstrong WE, Wilson CJ, Gallagher MJ and Sladek CD: The relationship between firing rates of supraoptic neurons and vasopressin release in vitro. In Vasopressin: Cellular and Integrative Functions, Edited by Cowley DA, Liard J-F and Ausiello DA, pp 355-361, Raven Press, New York (1988)
9. Qadri F, Culman J, Veltmar A, Maas K, Rascher W and Unger T: Angiotensin II-induced vasopressin release is mediated through alpha-1 adrenoceptors and angiotensin II AT1 receptors in the supraoptic nucleus. J Pharmacol Exp Ther 267, 567-574 (1993)
10. Gribkoff VK, Christian EP, Robinson JH, Deadwyler SA and Dudek F E: Cholinergic excitation of supraoptic neurons in hypothalamic slices of rat. Neuropharmacology 27, 721-727 (1988)
11. Mori M, Tsushima H and Matsuda T: Effect of vasopressin antagonist on antidiuresis by oxotremorine microinjected into the hypothalamic supraoptic and paraventricular nuclei in a water-loaded and ethanol-anesthetized rat. Jpn J Pharmacol 49, 357-364 (1989)
12. Veltmar A, Culman J, Qadri F, Rascher W and Unger T: Involvement of adrenergic and angiotensinergic receptors in the paraventricular nucleus in the angiotensin II-induced vasopressin release. J Pharmacol Exp Ther 263, 1253-1260 (1992)
13. Jarvis CR, Bourque CW and Renaud LP: Depolarizing action of cholecystokimin on rat supraoptic neurones in vitro. J Physiol (Lond) 458, 621-632 (1992)
14. Leibowitz SF: Impact of brain monoamines and neuropeptides on vasopressin release. In Vasopressin: Cellular and Integrative Functions, Edited by Cowley AW Jr, Liard J-F and Ausiello DA, pp 379- 388, Raven Press, New York (1988)
15. Mori M, Tsushima H and Matsuda T: Substance P injected into the hypothalamic supraoptic nucleus causes antidiuresis through the release of arginine-vasopressin in water-loaded and ethanol-anesthetized rats. Jpn J Pharmacol 62, 49-56 (1993)
16. Raadsheer FC, Sluiter AA, Ravid R, Tilders, FJH and Swaab DF: Localization of corticotropin-releasing hormone (CRH) neurons in the paraventricular nucleus of the human hypothalamus; age-dependent colocalization with vasopressin. Brain Res 615, 50-62 (1993)
17. Raff H: Interactions between vasopressin and the CRF-ACTH-adrenocortical control system. In Vasopressin: Cellular and Integrative Functions, Edited by Cowley AW, Liard J-F and Ausiello DA, pp 363-369, Raven Press, New York (1988)
18. Timmermans PBMWM, Wong PC, Chiu AT, Herblin WF, Benfield P, Carini DJ, Lee RJ, Wexler RR, Saye JAM and Smith RD: Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev 45, 205-251 (1993)
19. 5-enkephalin, microinjected into the supraoptic and para-ventricular nuclei, on urine outflow rate. Jpn J Pharmacol 63, 181-186 (1993)
20. Tsushima H, Mori M and Matsuda T: Microinjection of dynorphin into the supraoptic and paraventricular nuclei produces antidiuretic effects through vasopressin release. Jpn J Pharmacol 63, 461-468 (1993)
21. Tsushima H, Mori M and Matsuda T: Microinjections of angiotensin II into the supraoptic and paraventricular nuclei produce potent antidiureses by vasopressin release mediated through adrenergic and angiotensin receptors. Jpn J Pharmacol 66, 241-246 (1994)
22. Roques BP, Noble F, Daugé V, Fournié-Zaluski M-C and Beaumont A: Neutral endopeptidase 24.11: Structure, inhibition, and experimental and clinical pharmacology. Pharmacol Rev 45, 87-146 (1993)
23. Schwartz J-C, Costentin J and Lecomte J-M: Pharmacology of enkephalinase inhibitors. Trends Pharmacol Sci 6, 472-476 (1985)
24. Sullivan MJ, Harding JW and Wright JW: Differential effects of aminopeptidase inhibitors on angiotensin-induced pressor responses. Brain Res 456, 249-253 (1988)
25. Sullivan MJ and Johnson AK: Amastatin potentiates drinking elicited by osmotic stimuli: evidence for peptidergic mediation of intracellular dehydration-induced thirst. Brain Res 590, 271-276 (1992)
26. Matsas R, Turner AJ and Kenny AJ: Endopeptidase-24.11 and aminopeptidase activity in brain synaptic membranes are jointly responsible for the hydrolysis of cholecystokinin octapeptide (CCK-8). FEBS Lett 175, 124-128 (1984)
27. Matsas R, Kenny AJ and Turner AJ: The metabolism of neuropeptides: the hydrolysis of peptides, including enkephalins, tachykinins and their analogues, by endopeptidase 24.11. Biochem J 223, 433-440 (1984)
28. König JFR and Klippel RA: The Rat Brain, a Stereotaxic Atlas of the Forebrain and Lower Parts of the Brain Stem. Williams and Wilkins Co, Baltimore (1963)
29. Hisada S, Fujimoto S, Kamiya T, Endo Y and Tsushima H: Antidiuresis of centrally administered amines and peptides and release of antidiuretic hormone from isolated rat neurohypophysis. Jpn J Pharmacol 27, 153-161 (1977)
30. Hofbauer KG, Mah SC and Opperman JR: Chronic blockade of vasopressin receptors in rats. J Cardiovasc Pharmacol 8, Supp 7, S56-S60 (1986)
31. Suh HH and Tseng LL-F: Intrathecal administration of thiorphan, bestatin, desipramine and fluoxetine differentially potentiate the antinociceptive effects induced by β-endorphin and morphine, administered intracerebroventricularly. Neuropharmacology 29, 207-214 (1990)
32. Chang K-J: Opioid receptors: Multiplicity and sequelae of ligand-receptor interactions. In The Receptors, Vol 1, Edited by Conn PM, pp 1-81, Academic Press, Inc, London (1984)
33. Tsushima H, Mori M and Matsuda T: Antidiuretic effects of morphine microinjected into the hypothalamic supraoptic and paraventricular nuclei in a water-loaded and ethanol-anesthetized rat. Jpn J Pharmacol 45, 449-457 (1987)
34. Desjardins GC, Brawer JR and Beaudet A: Distribution of μ, δ and κ opioid receptors in the hypothalamus of the rat. Brain Res 536, 114-123 (1990)
35. Fallon JH and Leslie FM: Distribution of dynorphin and enkephalin peptides in the rat brain. J Comp Neurol 249, 293-336 (1986)
36. Mansour A, Khachaturian H, Lewis ME, Akil H and Watson SJ: Anatomy of CNS opioid receptors. Trends Neurosci 11, 308-314 (1988)
37. Tsushima H, Mori M and Matsuda T: Antidiuretic effects of methionine-enkephalin and 2-D-alanine-5-methionine-enkephalinamide microinjected into the hypothalamic supraoptic and paraventricular nuclei in a water-loaded and ethanol-anesthetized rat. Jpn J Pharmacol 42, 507-515 (1986)
38. Coquerel A, Dubuc I, Menard J-F, Kitabgi P and Costentin J: Naloxone-insensitive potentiation of neurotensin hypothermic effect by the enkephalinase inhibitor thiorphan. Brain Res 398, 386-389 (1986)
39. Griesbacher T, Leighton GE, Hill RG and Hughes J: Reduction of food intake by central administration of cholecystokinin octapeptide in the rat is dependent upon inhibition of brain peptidases. Br J Pharmacol 96, 236-242 (1989)
40. Hill RG, Hughes J and Pittaway KM: Antinociceptive action of cholecystokinin octapeptide (CCK 8) and related peptides in rats and mice: Effects of naloxone and peptidase inhibitors. Neuropharmacology 26, 289-300 (1987)
41. Smits GJ, McGraw DE and Trapani AJ: Interaction of ANP and bradykinin during endopeptidase 24.11 inhibition: renal effects. Am J Physiol 258, F1417-F1424 (1990)
42. Castrén E and Saavedra JM: Lack of vasopressin increases hypothalamic atrial natriuretic peptide binding sites. Am J Physiol 257, R168-R173 (1989)
43. Mori M, Tsushima H and Matsuda T: Antidiuretic effects of oxotremorine microinjected into the hypothalamic supraoptic and paraventricular nuclei in a water-loaded and ethanolanesthetized rat. Jpn J Pharmacol 35, 27-36 (1984)
44. Fujimoto S and Hisada S: Effects of intracerebroventricular morphine and enkephalins on the urine outflow in ethanolanesthetized rats. Nagoya Med J 23, 1-10 (1978)
45. 2 as a modulator. Jpn J Pharmacol 28, 33-40 (1978)
46. 2-adrenoceptor agonists applied into the hypothalamic paraventricular nuclei of spontaneously hypertensive rats on urine production. Jpn J Pharmacol 64, 201-207 (1994)